Posts from July 2019.

On July 22, 2019, the FDA issued a warning letter to Curaleaf, Inc. relating to statements on its website relating to claims about its CBD products.  The FDA warned that four of its products (CBD lotion, pain-relief patch, tincture and disposable vape pen) are unapproved new drugs and misbranded drugs.

Despite the growing popularity of CBD products, the FDA has issued previous warning letters and made clear that it will enforce the Federal Food, Drug & Cosmetics Act (FD&C), especially when merchants make claims about the health benefits of CBD.

The FDA issued this warning because ...

On July 15, 2019, the NJ Department of Health released the application forms required to be completed to apply for medical cannabis licenses pursuant to the request for applications released last month.  Forms are available from the DOH website here.

This RFA makes available up to 24 new medical cannabis license endorsements: 2 cultivation endorsements, 5 dispensary endorsements and 1 vertically integrated permit in each of the Northern and Central Regions of the state; and 1 cultivation endorsement, 5 dispensary endorsements and 1 vertically integrated permit in the Southern ...

Stay Connected

Recent Posts


Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use